These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 8445292

  • 1. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
    Sultan Y, Loyer F.
    J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
    [Abstract] [Full Text] [Related]

  • 2. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
    Bolliger D, Szlam F, Molinaro RJ, Escobar MA, Levy JH, Tanaka KA.
    Haemophilia; 2010 May; 16(3):510-7. PubMed ID: 20050927
    [Abstract] [Full Text] [Related]

  • 3. Thrombin generation assay as a possible tool for assessment of reduced activity of clotting factors induced by antiphospholipid antibodies and in-vitro evaluation of treatment options.
    Livnat T, Zivelin A, Tamarin I, Guetta V, Salomon O.
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):661-6. PubMed ID: 19730246
    [Abstract] [Full Text] [Related]

  • 4. Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/II study.
    Spira J, Plyushch O, Zozulya N, Yatuv R, Dayan I, Bleicher A, Robinson M, Baru M.
    Haemophilia; 2010 Nov; 16(6):910-8. PubMed ID: 20491957
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
    Warren DL, Morrissey JH, Neuenschwander PF.
    Biochemistry; 1999 May 18; 38(20):6529-36. PubMed ID: 10350471
    [Abstract] [Full Text] [Related]

  • 7. The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations.
    Bolliger D, Szlam F, Azran M, Koyama K, Levy JH, Molinaro RJ, Tanaka KA.
    Anesth Analg; 2010 Sep 18; 111(3):601-8. PubMed ID: 20686004
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available.
    Wielders SJ, Béguin S, Hemker HC, Lindhout T.
    Arterioscler Thromb Vasc Biol; 2004 Jun 18; 24(6):1138-42. PubMed ID: 15072993
    [Abstract] [Full Text] [Related]

  • 11. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay.
    Turecek PL, Váradi K, Keil B, Negrier C, Berntorp E, Astermark J, Bordet JC, Morfini M, Linari S, Schwarz HP.
    Pathophysiol Haemost Thromb; 2003 Jun 18; 33(1):16-22. PubMed ID: 12853708
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.
    Kjalke M, Monroe DM, Hoffman M, Oliver JA, Ezban M, Roberts HR.
    Thromb Haemost; 1998 Oct 18; 80(4):578-84. PubMed ID: 9798973
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A possible mechanism of action of activated factor VII independent of tissue factor.
    Monroe DM, Hoffman M, Oliver JA, Roberts HR.
    Blood Coagul Fibrinolysis; 1998 Mar 18; 9 Suppl 1():S15-20. PubMed ID: 9819024
    [Abstract] [Full Text] [Related]

  • 17. Modeling the action of factor VIIa in dilutional coagulopathy.
    Monroe DM.
    Thromb Res; 2008 Mar 18; 122 Suppl 1():S7-S10. PubMed ID: 18691504
    [Abstract] [Full Text] [Related]

  • 18. Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors.
    Hough RE, Hampton KK, Preston FE, Channer KS, West J, Makris M.
    Br J Haematol; 2000 Dec 18; 111(3):974-9. PubMed ID: 11122162
    [Abstract] [Full Text] [Related]

  • 19. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR, Kevy SV.
    Pediatrics; 1978 Nov 18; 62(5):767-74. PubMed ID: 724319
    [Abstract] [Full Text] [Related]

  • 20. Combination of FVIII and by-passing agent potentiates in vitro thrombin production in haemophilia A inhibitor plasma.
    Klintman J, Astermark J, Berntorp E.
    Br J Haematol; 2010 Nov 18; 151(4):381-6. PubMed ID: 20977448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.